NRGN and Alzheimer disease: Several studies reported CSF concentrations of the presynaptic proteins, such as growth-associated protein 43 (GAP-43), synaptosomal-associated protein 25 (SNAP-25) and synaptotagmin-1, as well as postsynaptic protein neurogranin are altered in AD patients5–8.